ECP
Epacria Capital Partners Portfolio holdings
AUM
$123M
1-Year Est. Return
18.77%
1 Year Est. Return
+18.77%
AUM
$120M
AUM Growth
-$3.14M
(-2.6%)
Holding
41
Top Buys
| 1 | +$536K | |
| 2 | +$523K | |
| 3 | +$467K | |
| 4 |
Valaris
VAL
|
+$325K |
| 5 |
ClearPoint Neuro
CLPT
|
+$140K |
Top Sells
| 1 | +$5.91M | |
| 2 | +$1.47M | |
| 3 | +$945K | |
| 4 |
Liberty Latin America Class C
LILAK
|
+$847K |
| 5 |
DaVita
DVA
|
+$628K |
Sector Composition
| 1 | Consumer Staples | 29.02% |
| 2 | Financials | 22.65% |
| 3 | Energy | 19.24% |
| 4 | Technology | 2.43% |
| 5 | Real Estate | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
New England Realty Associates
NEN
$244M
| $631K | 0.53% |
8,636
|
|
||
27
Diageo
DEO
$52.6B
| $402K | 0.34% |
3,989
|
|
||
|
28
Valaris Ltd Warrants
VAL.WS
$212M
| $323K | 0.27% |
83,658
|
|
||
29
Mid-America Apartment Communities
MAA
$15.3B
| $297K | 0.25% |
2,008
|
|
||
30
Expeditors International
EXPD
$18.6B
| $251K | 0.21% |
2,200
|
|
||
|
CRESW
31
Cresud SACIF y A. Warrant
CRESW
$65.4M
| $249K | 0.21% |
295,967
|
|
||
32
Maravai LifeSciences
MRVI
$528M
| $226K | 0.19% |
93,694
+38,264
|
|
||
|
33
ClearPoint Neuro
CLPT
$439M
| $140K | 0.12% |
+11,729
|
|
||
34
MaxCyte
MXCT
$168M
| $135K | 0.11% |
62,133
+39,796
|
|
||
|
35
DaVita
DVA
$8.58B
| – | – |
-4,107
|
|
||
36
Royalty Pharma
RPRX
$16.7B
| – | – |
-18,440
|
|
||
37
Park Aerospace
PKE
$383M
| – | – |
-70,282
|
|
||
|
38
Liberty Latin America Class C
LILAK
$1.65B
| – | – |
-137,754
|
|
||
39
Jefferies Financial Group
JEF
$11.4B
| – | – |
-27,381
|
|
||
40
Burford Capital
BUR
$1.88B
| – | – |
-23,291
|
|
||
41
A-Mark Precious Metals
AMRK
$622M
| – | – |
-16,600
|
|